PMDA drug package insert
ミオMIBG−I123注射液
PMDA Prescription drug · PDRファーマ株式会社 · package insert Dec 22, 2023
Key facts
| Brand names | ミオMIBG−I123注射液 |
|---|---|
| Nonproprietary names | ３－ヨードベンジルグアニジン（１２３Ｉ） |
| Companies | 製造販売元／PDRファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 放射性医薬品／心交感神経診断薬・神経芽腫診断薬・褐色細胞腫診断薬 |
| Therapeutic category codes | 874300 |
| YJ codes | 4300437A1029 |
| Approval numbers | 20400AMZ01122000 |
| Package insert edition | 第3版 |
| Package insert date | Dec 22, 2023 |
| PMDA document key | 651410_4300437A1029_2 |
| PMDA company code | 651410 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: